Chotima Bottcher

Berlin, BE, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 53 publications

Immuno-Proteomic Features Associated to Relapse Risk in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease.

Immuno-Proteomic Features Associated to Relapse Risk in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: June 23, 2026

Targeting formyl peptide receptor 1 reduces brain inflammation and neurodegeneration.

Targeting formyl peptide receptor 1 reduces brain inflammation and neurodegeneration.

Journal: Science (New York, N.Y.)

Published: November 13, 2025

Correction: Generation of decellularized human brain tissue for investigating cell-matrix interactions: a proof-of-concept study.

Correction: Generation of decellularized human brain tissue for investigating cell-matrix interactions: a proof-of-concept study.

Journal: Frontiers in bioengineering and biotechnology

Published: August 22, 2025

Immune-proteo-metabolomic changes link to Aβ and tau pathology in Alzheimer disease.

Immune-proteo-metabolomic changes link to Aβ and tau pathology in Alzheimer disease.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: August 06, 2025

Rapamycin treatment reduces CD11c+ microglia and increases amyloid plaque load in 5xFAD mice.

Rapamycin treatment reduces CD11c+ microglia and increases amyloid plaque load in 5xFAD mice.

Journal: Experimental neurology

Published: August 03, 2025

Glial Fibrillary Acidic Protein Astrocytopathy Based on a Two-Center Chinese Cohort Study.

Glial Fibrillary Acidic Protein Astrocytopathy Based on a Two-Center Chinese Cohort Study.

Journal: Annals of clinical and translational neurology

Published: March 10, 2025

Immunomodulatory activity of isolated phenanthrene and dihydrophenanthrene derivatives (coelotrinins A-L) from Coelogyne trinervis.

Immunomodulatory activity of isolated phenanthrene and dihydrophenanthrene derivatives (coelotrinins A-L) from Coelogyne trinervis.

Journal: Phytochemistry

Published: March 10, 2025

Generation of decellularized human brain tissue for investigating cell-matrix interactions: a proof-of-concept study.

Generation of decellularized human brain tissue for investigating cell-matrix interactions: a proof-of-concept study.

Journal: Frontiers in bioengineering and biotechnology

Published: February 17, 2025

Immunomodulatory Potential of a Bibenzyl-dihydrophenanthrene Derivative Isolated from Calanthe cardioglossa.

Immunomodulatory Potential of a Bibenzyl-dihydrophenanthrene Derivative Isolated from Calanthe cardioglossa.

Journal: Journal of natural products

Published: January 29, 2025

New phenanthrenequinones from Cymbidium ensifolium roots and their anti-inflammatory activity on lipopolysaccharide-activated BV2 microglial cells.

New phenanthrenequinones from Cymbidium ensifolium roots and their anti-inflammatory activity on lipopolysaccharide-activated BV2 microglial cells.

Journal: RSC advances

Published: July 01, 2024

Comprehensive analysis of B cell repopulation in ocrelizumab-treated patients with multiple sclerosis by mass cytometry and proteomics.

Comprehensive analysis of B cell repopulation in ocrelizumab-treated patients with multiple sclerosis by mass cytometry and proteomics.

Journal: iScience

Published: May 14, 2024

Protocol of a prospective multicenter study on comorbidity impact on multiple sclerosis and antibody-mediated diseases of the central nervous system (COMMIT).

Protocol of a prospective multicenter study on comorbidity impact on multiple sclerosis and antibody-mediated diseases of the central nervous system (COMMIT).

Journal: Frontiers in immunology

Published: January 31, 2024

Showing 1-12 of 53

Last Updated: 09/26/2026